In-house r&d projects

ProtectomiR

ProtectomiR project: open for out-licensing and/or co-development partnership

mirna

Summary of invention:

Several miRNA compounds for cytoprotection in ischemic diseases, method of identification for cytoprotective miRNA targets, termed “protectomiRs”.

IP status:

  • Patented technology (primary filing date Oct,  2011, WO_2013/057527_A2)
  • Granted in USA and EU,  in national phase in China
  • protectomiR, pathomiR, therapomiR, toxicomiR, and diagnomiR are trademarks of Pharmahungary, see www.protectomir.com

If you are interested in our project as an investor or co-development partner, please contact us for further details at businessdevelopment@pharmahungary.com.